Dr. Tim Meyer | Research Group Leader
University Medical Center Göttingen

Dr. Tim Meyer leads the Pharmacological Biotechnology Workgroup at the Department of Pharmacology and Toxicology, University Medical Center Göttingen (UMG). His research centers on developing animal-free drug testing technologies, focusing on automated, high-throughput platforms with engineered human myocardium (EHM) and advanced 3D bioprinting for cardiac tissue engineering and clinical translation. His pioneering approach has resulted in robust multiwell platforms for cardiac tissue generation and analysis, now markketed as myrPlate and myrImager by a spin-off company myriamed GmbH, where he is head of automation. In addition to his academic role, Dr. Meyer is President of the smartlab society, where he drives innovation in laboratory digitalization and automation. He serves as Board Member and Treasurer of the SiLA Consortium, actively promoting open standards for laboratory automation, and is Head of Automation at myriamed, leading the implementation of advanced bioengineering solutions. Dr. Meyer holds a PhD in Biomedicine from the University of Barcelona and has held research positions at the Max Planck Institute for Biophysical Chemistry, The Scripps Institute, and leading institutions in Australia, France, and Germany. His scientific contributions have been recognized with major research grants and awards, including the BMBF-funded autoOrgan.3R project and the Animal Welfare Research Award. He is widely published in high-impact journals and is a frequent speaker on laboratory automation, AI in biomedical research, and engineered tissue models for drug screening. Contact:
Pharmacological Biotechnology Workgroup, Department of Pharmacology and Toxicology
University Medical Center Göttingen
Robert-Koch-Straße 40, 37075 Göttingen
tim.meyer(at)med.uni-goettingen.de
ORCID: 0000-0002-0521-6711